Atria Wealth Solutions Inc. Has $457,000 Stock Holdings in Haleon plc (NYSE:HLN)

Atria Wealth Solutions Inc. increased its holdings in Haleon plc (NYSE:HLN) by 6.1% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 47,868 shares of the company’s stock after acquiring an additional 2,758 shares during the period. Atria Wealth Solutions Inc.’s holdings in Haleon were worth $457,000 at the end of the most recent quarter.

Other large investors have also added to or reduced their stakes in the company. Sierra Ocean LLC bought a new stake in Haleon during the fourth quarter worth $26,000. Fortitude Family Office LLC purchased a new position in shares of Haleon in the 3rd quarter worth approximately $28,000. Versant Capital Management Inc boosted its position in Haleon by 2,029.1% in the fourth quarter. Versant Capital Management Inc now owns 3,513 shares of the company’s stock worth $34,000 after purchasing an additional 3,348 shares during the last quarter. Geneos Wealth Management Inc. purchased a new stake in shares of Haleon during the 4th quarter valued at approximately $35,000. Finally, Toronto Dominion Bank grew its holdings in Haleon by 3,470.0% during the 3rd quarter. Toronto Dominion Bank now owns 3,570 shares of the company’s stock valued at $38,000 after buying an additional 3,470 shares in the last quarter. Institutional investors own 6.67% of the company’s stock.

Analysts Set New Price Targets

Several research firms have weighed in on HLN. Morgan Stanley cut Haleon from an “overweight” rating to an “equal weight” rating in a report on Friday, January 10th. Sanford C. Bernstein downgraded Haleon from an “outperform” rating to a “market perform” rating in a research report on Wednesday, January 8th. Three research analysts have rated the stock with a hold rating, three have given a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $10.95.

Haleon Price Performance

HLN stock opened at $9.81 on Friday. The company has a current ratio of 0.84, a quick ratio of 0.58 and a debt-to-equity ratio of 0.44. Haleon plc has a 12-month low of $7.89 and a 12-month high of $10.80. The stock has a market capitalization of $44.39 billion, a price-to-earnings ratio of 28.84, a PEG ratio of 2.82 and a beta of 0.28. The firm’s 50-day moving average price is $9.59 and its two-hundred day moving average price is $9.83.

Haleon (NYSE:HLN) last released its quarterly earnings results on Thursday, February 27th. The company reported $0.05 earnings per share (EPS) for the quarter. Haleon had a net margin of 10.85% and a return on equity of 14.76%. As a group, equities analysts predict that Haleon plc will post 0.43 earnings per share for the current year.

Haleon Company Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.